Back to Cetera Investment Advisers Cetera Investment Advisers

MRNAMRNA

Showing 8 of 25 quarters

Position history for Cetera Investment AdvisersCetera Investment Advisers's holdings in Moderna, Inc.

Yes. Cetera Investment Advisers holds 61,287 shares of MRNA (Moderna), worth $4.3M, as of its Q2 2026 13F filing. It reduced the position by 20,019 shares (-24.6%) from Q1 2026. Cetera Investment Advisers has held MRNA since Q4 2020, across 23 quarterly 13F filings.

Current Value

$4.3M

Current Shares

61,287

Total Value Change

+$1.8M

Total Shares Change

+23,625

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
61,287
-24.6%
$4.3M0.0%$70.03
0
2026-Q1
Increased
81,306
+28.1%
$4.1M0.0%$50.80
33
2025-Q4
Decreased
63,447
-12.7%
$1.9M0.0%$29.49
0
2025-Q3
Increased
72,671
+17.0%
$1.9M0.0%$25.83
30
2025-Q2
Increased
62,131
+26.2%
$1.7M0.0%$27.59
32
2025-Q1
Increased
49,215
+20.7%
$1.4M0.0%$28.35
30
2024-Q4
Increased
40,783
+8.3%
$1.7M0.0%$41.58
28
2024-Q3
Decreased
37,662
-42.6%
$2.5M0.0%$65.75
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used